Human ARF protein interacts with Topoisomerase I and stimulates its activity

被引:78
|
作者
Karayan, L
Riou, JF
Séité, P
Migeon, J
Cantereau, A
Larsen, CJ [1 ]
机构
[1] CHU Poitiers, Lab Biochim Prot, Poitiers, France
[2] Oncol Mol Lab, CNRS, FRE 2224, Poitiers, France
[3] IFR Commun Intercellulaire, CNRS, UMR 6558, Serv Cytofluorometrie, F-86021 Poitiers, France
[4] Rhone Poulenc Rorer, Ctr Rech Vitry Alfortville, Aventis Pharma, F-94403 Vitry Sur Seine, France
关键词
p14(ARF); Topoisomerase I; protein interactions;
D O I
10.1038/sj.onc.1204170
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ARF gene (p19(ARF) in mouse and p14(ARF) in man) has become a central actor of the cell cycle regulation process as it participates to the ARF-MDM2-p53 pathway and the Rh-E2F-1 pathway. By use of immunoprecipitation and Western blotting (IP/WB), we now show that ARF physically associates with Topoisomerase I(Topo I), ARF-Topo I immune complexes were detected in SF9 insect cells infected with recombinant baculoviruses encoding the two genes as well as in 293 cells that express endogeneously these proteins. Preparations of a GST-ARF recombinant protein stimulated the DNA relaxation activity of Topo I but, in contrast, had no effect an the decatenation activity of Topo TT, The Topo I stimulation was also detected in cell extracts of SF9 cells expressing both proteins, A confocal microscopy study indicated that part of ARF and Topo I colocalized in the granular component structure of the nucleolus. As a whole, our data indicate that Topo I is a new partner of ARF and suggest that ARF is involved in cell reactions that require Topo I.
引用
收藏
页码:836 / 848
页数:13
相关论文
共 50 条
  • [41] Determinants of cisplatin and irinotecan activities in human lung adenocarcinoma cells: Evidence of cisplatin accumulation and topoisomerase I activity
    Matsumura, T
    Takigawa, N
    Kiura, K
    Shibayama, T
    Chikamori, M
    Tabata, M
    Ueoka, H
    Tanimoto, M
    IN VIVO, 2005, 19 (04): : 717 - 721
  • [42] Benzoxazines as new human topoisomerase I inhibitors and potential poisons
    Foto, Egemen
    Ozen, Cigdem
    Zilifdar, Fatma
    Tekiner-Gulbas, Betul
    Yildiz, Ilkay
    Aki-Yalcin, Esin
    Diril, Nuran
    Yalcin, Ismail
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 28 (01) : 65 - 73
  • [43] Benzoxazines as new human topoisomerase I inhibitors and potential poisons
    Egemen Foto
    Çigdem Özen
    Fatma Zilifdar
    Betül Tekiner-Gülbaş
    İlkay Yıldız
    Esin Akı-Yalçın
    Nuran Diril
    İsmail Yalçın
    DARU Journal of Pharmaceutical Sciences, 2020, 28 : 65 - 73
  • [44] Stereoselective synthesis of 11-phenylundeca-5Z,9Z-dienoic acid and investigation of its human topoisomerase I and IIα inhibitory activity
    D'yakonov, Vladimir A.
    Dzhemileva, Lilya U.
    Makarov, Aleksey A.
    Mulukova, Alfiya R.
    Baev, Dmitry S.
    Khusnutdinova, Elza K.
    Tolstikova, Tatiana G.
    Dzhemilev, Usein M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (11) : 2405 - 2408
  • [45] The human topoisomerase I damage response plays a role in apoptosis
    Soe, K
    Rockstroh, A
    Schache, P
    Grosse, F
    DNA REPAIR, 2004, 3 (04) : 387 - 393
  • [46] Elevated topoisomerase I activity in cervical cancer as a target for chemoradiation therapy
    Chen, BM
    Chen, JY
    Kao, M
    Lin, JB
    Yu, MH
    Roffler, SR
    GYNECOLOGIC ONCOLOGY, 2000, 79 (02) : 272 - 280
  • [47] LIPOSOMAL ENCAPSULATION INCREASES THE ACTIVITY OF THE TOPOISOMERASE-I INHIBITOR TOPOTECAN
    SUBRAMANIAN, D
    MULLER, MT
    ONCOLOGY RESEARCH, 1995, 7 (09) : 461 - 469
  • [48] Enhanced topoisomerase I activity and increased topoisomerase IIα content in cisplatin-resistant cancer cell lines
    Minagawa, Y
    Kigawa, J
    Irie, T
    Kanamori, Y
    Itamochi, H
    Cheng, XS
    Terakawa, N
    JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (12): : 1218 - 1223
  • [49] DNA-topoisomerase I activity and content in epithelial ovarian cancer
    Codegoni, AM
    Castagna, S
    Mangioni, C
    Scovassi, AI
    Broggini, M
    D'Incalci, M
    ANNALS OF ONCOLOGY, 1998, 9 (03) : 313 - 319
  • [50] SF2/ASF protein binds to the cap region of human topoisomerase I through two RRM domains
    Kowalska-Loth, B
    Girstun, A
    Trzcinska, AM
    Piekielko-Witkowska, A
    Staron, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 331 (02) : 398 - 403